In both human and mouse AD models, exposure to amyloid-β (Aβ42 oligomers) directly reduces endothelial Cldn5, impairing the barrier integrity and contributing to progressive neurodegeneration [84]. The gene discussed is CLDN5; the disease is Alzheimer disease.